BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32316552)

  • 1. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics.
    Gomarasca M; Maroni P; Banfi G; Lombardi G
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in the control of metastatic bone disease.
    Browne G; Taipaleenmäki H; Stein GS; Stein JL; Lian JB
    Trends Endocrinol Metab; 2014 Jun; 25(6):320-7. PubMed ID: 24811921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and Their Roles in Breast Cancer Bone Metastasis.
    Puppo M; Valluru MK; Clézardin P
    Curr Osteoporos Rep; 2021 Jun; 19(3):256-263. PubMed ID: 33830428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Metastasis-Related MicroRNAs: New Targets for Treatment?
    Zhao Q; Luo F; Ma J; Yu X
    Curr Cancer Drug Targets; 2015; 15(8):716-25. PubMed ID: 26119014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
    Kawaguchi T; Yan L; Qi Q; Peng X; Edge SB; Young J; Yao S; Liu S; Otsuji E; Takabe K
    Ann Surg Oncol; 2018 Dec; 25(13):4037-4046. PubMed ID: 30311168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
    Greene SB; Herschkowitz JI; Rosen JM
    Curr Drug Targets; 2010 Sep; 11(9):1059-73. PubMed ID: 20545613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of breast cancer metastasis signaling by miRNAs.
    Petri BJ; Klinge CM
    Cancer Metastasis Rev; 2020 Sep; 39(3):837-886. PubMed ID: 32577859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
    Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Regulatory Role of MicroRNAs in Breast Cancer.
    Loh HY; Norman BP; Lai KS; Rahman NMANA; Alitheen NBM; Osman MA
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.
    Abdul Manap AS; Wisham AA; Wong FW; Ahmad Najmi HR; Ng ZF; Diba RS
    Front Cell Dev Biol; 2024; 12():1390704. PubMed ID: 38726321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
    Shi M; Liu D; Duan H; Shen B; Guo N
    Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs: Critical mediators of breast cancer metastatic programming.
    Nair MG; Somashekaraiah VM; Ramamurthy V; Prabhu JS; Sridhar TS
    Exp Cell Res; 2021 Apr; 401(1):112518. PubMed ID: 33607102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-429 inhibits migration and invasion of breast cancer cells in vitro.
    Ye ZB; Ma G; Zhao YH; Xiao Y; Zhan Y; Jing C; Gao K; Liu ZH; Yu SJ
    Int J Oncol; 2015 Feb; 46(2):531-8. PubMed ID: 25405387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting microRNAs as key modulators of tumor immune response.
    Paladini L; Fabris L; Bottai G; Raschioni C; Calin GA; Santarpia L
    J Exp Clin Cancer Res; 2016 Jun; 35():103. PubMed ID: 27349385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
    Naser Al Deen N; Nassar F; Nasr R; Talhouk R
    Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.